SG/CALL/UCB/110/0.1/20.12.24 | Market Closed - Euronext Paris 11:53:33 2024-07-01 EDT | ||
| 3.565 EUR | +7.87% |
|
| 1 month | +37.14% | ||
| 3 months | +113.23% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
UCB
Latest news about UCB
More news
| Date | Price | Change |
|---|---|---|
| 24-07-01 | 3.565 | +7.87% |
| 24-06-28 | 3.305 | 0.00% |
| 24-06-27 | 3.305 | +3.61% |
| 24-06-26 | 3.19 | -0.31% |
| 24-06-25 | 3.2 | -3.32% |
Real-time Euronext Paris
Last update July 01, 2024 at 11:53 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | UCB |
| Issuer | 
Société Générale
|
| H929S | |
| ISIN | DE000SU9BW56 |
| Date issued | 2024-02-14 |
| Strike | 110 € |
| Maturity | 2024-12-20 (172 Days) |
| Parity | 10 : 1 |
| Emission price | 0.45 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.715 € |
|---|---|
| Lowest since issue | 0.44 € |
| Spread | 0.12 € |
| Spread % | 3.31% |
Company Profile
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Sector
-
Consensus: UCB
Sell
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
138.7
EUR
Average target price
139.7
EUR
Spread / Average Target
+0.72%
- Stock Market
- Warrants
- H929S Warrant
